Back
Interpace Biosciences, Inc. 10K Form
Sell
42
IDXG
Interpace Biosciences, Inc.
Last Price:
$1.85
Seasonality Move:
-5.87%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive IDXG News And Ratings
See the #1 stock for the next 7 days that we like better than IDXG
IDXG Financial Statistics
Sales & Book Value
| Annual Sales: | $46.9M |
|---|---|
| Cash Flow: | $1.8M |
| Price / Cash Flow: | 6.71 |
| Annual Sales: | $-0.07 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | 0.26900 |
|---|---|
| Net Income (TTM): | $4.1M |
| Gross Margin: | $29.9M |
| Return on Equity: | 0% |
| Return on Assets: | 30.26% |
Interpace Biosciences, Inc. Earnings Forecast
Key Interpace Biosciences, Inc. Financial Ratios
-
The Gross Profit Margin over the past 28 years for IDXG is 63.77%.
-
The Selling, General & Administrative Expenses for IDXG have been equal to 45.05% of Gross Profit Margin.
-
The Research & Development expenses have been 1.44% of Revenue.
-
The Interest Expense is 9.49% of Operating Income.
-
The Net Earning history of IDXG is 14.80% of Total Revenues.
-
Per Share Earnings over the last 28 years have been positive in 14 years.
Interpace Biosciences, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Health Care Providers & Services |
| Sector: | Health Care |
| Current Symbol: | IDXG |
| CUSIP: | 46062X |
| Website: | interpacediagnostics.com |
Debt
| Debt-to-Equity Ratio: | -7.58 |
|---|---|
| Current Ratio: | 1.54 |
| Quick Ratio: | 1.24 |
Price-to-Earnings
| Trailing P/E Ratio: | 4.67 |
|---|---|
| Forward P/E Ratio: | 0 |
IDXG Technical Analysis vs Fundamental Analysis
Sell
42
Interpace Biosciences, Inc. (IDXG)
is a Sell
Is Interpace Biosciences, Inc. a Buy or a Sell?
-
Interpace Biosciences, Inc. stock is rated a SellThe current Interpace Biosciences, Inc. [IDXG] share price is $1.85. The Score for IDXG is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.